SDHB and neoplasm: Given that these effects are contrary to tumor cell respiration (i.e., panobinostat increases, whereas gamitrinib suppresses the oxygen consumption rate (OCR)) through disruption of the complex II of the respiratory chain (SDH), we hypothesized that gamitrinib might suppress panobinostat mediated increase in oxygen consumption rate.